e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Janux Therapeutics, Inc. - Common Stock
(NQ:
JANX
)
16.54
-0.57 (-3.33%)
Streaming Delayed Price
Updated: 2:09 PM EST, Dec 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Janux Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Janux Therapeutics Appoints Ron Barrett, Ph.D., and Alana McNulty to Board of Directors
September 09, 2021
From
Janux Therapeutics, Inc.
Via
Business Wire
Janux Therapeutics to Present Virtually at the H.C. Wainwright 23rd Annual Global Investor Conference
September 07, 2021
From
Janux Therapeutics, Inc.
Via
Business Wire
Janux Therapeutics Appoints Shahram Salek-Ardakani, Ph.D., Chief Scientific Officer
July 19, 2021
From
Janux Therapeutics
Via
Business Wire
84 Biggest Movers From Friday
↗
August 09, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2021
↗
July 06, 2021
Upgrades According to Citigroup, the prior rating for ORIC Pharmaceuticals Inc (NASDAQ:
Via
Benzinga
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
↗
July 03, 2021
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...
Via
Benzinga
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
↗
June 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...
Via
Benzinga
Janux Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 15, 2021
From
Janux Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
↗
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
June 15, 2021
Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as...
Via
Benzinga
Opening Day: Monday.com, Marqeta Jump In Market Debuts
↗
June 13, 2021
Monday.com jumped in its U.S. debut after the workplace management software maker raised $574M in its initial public offering. Meanwhile, Marqeta's shares also soared on their first day of trading on...
Via
Talk Markets
64 Biggest Movers From Friday
↗
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Mid-Afternoon Market Update: Crude Oil Rises 1%; Janux Therapeutics Shares Jump
↗
June 11, 2021
Toward the end of trading Friday, the Dow traded down 0.1% to 34,432.88 while the NASDAQ rose 0.16% to 14,043.26. The S&P also rose, gaining 0.04% to 4,240.72. The U.S. has...
Via
Benzinga
Topics
Stocks
46 Stocks Moving In Friday's Mid-Day Session
↗
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...
Via
Benzinga
Topics
Initial Public Offering
Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher
↗
June 11, 2021
Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73. The U.S. has the...
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.